Abstract CT008: First-in-human study of SYS6010, a novel EGFR targeting antibody drug conjugate (ADC) for patients with advanced solid tumors
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1158/1538-7445.AM2025-CT008
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Shun Lu; Zhen Zhou; Zi-Ming Li; Zhi-Yong HE; Jian Fang; Hong-Mei Sun; Yi Gong; Ying Cheng; Yi-Bing LIU; Yu Yao; Yan Yu; Yan-Hong Shang; Xiang-Lin Yuan; Liang Han; Mingjun Zhang; Kun-Yu Yang; Liqiong Zhang; Xuechao Wan; Huanhuan Qi; Yang Yang
全文下载地址: https://aacrjournals.org/cancerres/article/85/8_Supplement_2/CT008/761554/Abstract-CT008-First-in-human-study-of-SYS6010-a

